Insider Trading July 6, 2026 06:45 PM

Everspin Technologies CEO Aggarwal Offloads Shares Amid Strategic Shifts

Executive divestment coincides with new defense contract and index inclusion, while analyst concerns linger over market positioning.

By Caleb Monroe
Share
Twitter Reddit Facebook LinkedIn
MRAM

Sanjeev Aggarwal, President and CEO of Everspin Technologies, executed a sale of 30,885 shares on July 1, 2026, generating $689,970 to cover tax liabilities from Restricted Stock Unit vesting. The transaction leaves him with 839,561 directly held shares. This financial move occurs against a backdrop of significant corporate developments, including a $40 million defense contract and inclusion in the Russell 2000 Index. Despite a recent stock decline of 12.92% over the past week to $19.62, the stock has surged 187% over the past year. Analyst perspectives remain divided, with Needham maintaining a Buy rating and a price target of $18.50, while Kerrisdale Capital raises concerns about Everspin's market focus.

Everspin Technologies CEO Aggarwal Offloads Shares Amid Strategic Shifts
MRAM
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • CEO Sanjeev Aggarwal sold 30,885 shares for $689,970 to cover tax obligations from RSU vesting, retaining 839,561 direct shares.
  • Everspin secured a $40 million defense contract and will be added to the Russell 2000 Index, signaling strategic growth.
  • Analyst views are divided: Needham maintains a Buy rating with an $18.50 target, while Kerrisdale Capital questions the company's market focus.

Sanjeev Aggarwal, the President and Chief Executive Officer of Everspin Technologies Inc., has executed a significant transaction involving the company's equity. On July 1, 2026, Aggarwal sold 30,885 shares of Everspin's common stock. The transaction, valued at $689,970, was completed at a price of $22.34 per share. The primary purpose of this sale was to satisfy tax obligations associated with the vesting of his Restricted Stock Units. Following this divestment, Aggarwal's direct holdings in Everspin Technologies stand at 839,561 shares.


Market data indicates that Everspin's stock price has experienced volatility since the executive's sale. The shares have declined to $19.62, marking a 12.92% drop over the past week. Despite this recent downward pressure, the stock has demonstrated substantial growth over a longer horizon, surging 187% over the past year. Valuation metrics from InvestingPro suggest that the stock is currently overvalued relative to its Fair Value, placing it among companies on the most overvalued list. Investors seeking deeper insights can access MRAM's comprehensive Pro Research Report, one of 1,400+ available on the platform.


Corporate developments at Everspin Technologies extend beyond executive transactions. The company announced a significant $40 million contract to provide Toggle MRAM process technology and engineering services for U.S. Defense Industrial Base customers. This agreement, spanning two and a half years, positions Everspin as a subcontractor on a prime contract with the U.S. Department of War. Additionally, Everspin Technologies will be added to the Russell 2000 Index, effective June 29, following its inclusion in the Russell 3000 Index. Shareholders have also approved amendments to the company's 2016 Equity Incentive Plan, authorizing an additional 1.8 million shares for issuance.


Analyst sentiment surrounding Everspin remains mixed. Needham has raised its price target for Everspin Technologies to $18.50, maintaining a Buy rating. This adjustment follows the company's first-quarter 2026 revenue surpassing expectations and the recent defense contract win. Conversely, a report from short seller Kerrisdale Capital has highlighted concerns, noting that Everspin's primary market is casino gaming rather than AI infrastructure, which is currently driving the semiconductor boom. Despite these divergent views, Everspin Technologies continues to make strategic moves in its business operations.

Risks

  • Everspin's primary market is casino gaming, not AI infrastructure, which may limit growth potential in the current semiconductor boom.
  • The stock is currently overvalued relative to its Fair Value, posing a risk for investors.
  • Recent stock decline of 12.92% over the past week indicates short-term volatility.

More from Insider Trading

Palisade Bio Director Robert Baltera Jr. Expands Position as FDA Clears Phase 2 Trial Jul 6, 2026 Sight Sciences CTO David Badawi Offloads $40,858 in Company Stock Jul 6, 2026 Sight Sciences Executive Sells Stock to Cover Tax Obligations Jul 6, 2026 Sight Sciences CLO Jeremy Hayden Sells $70,133 in Stock Jul 6, 2026 Sight Sciences CFO James Rodberg Offloads $36,994 Worth of SGHT Shares Jul 6, 2026